State the therapeutic indications, drug interactions and side effects of Methotrexate.
5 marks · directive: State
The core of a good answer
Methotrexate, an antifolate that competitively inhibits dihydrofolate reductase, is used in cancers (acute lymphoblastic leukaemia, choriocarcinoma, breast cancer, non-Hodgkin lymphoma, osteosarcoma), autoimmune disease (rheumatoid arthritis, psoriasis, Crohn's disease) and ectopic pregnancy with an unruptured tube; NSAIDs, penicillins, probenecid, trimethoprim-sulfamethoxazole and proton pump inhibitors raise its levels or toxicity, and its side effects include blood abnormalities (leucopenia, anaemia, thrombocytopenia), mucositis, hepatotoxicity, pneumonitis, renal impairment and teratogenicity, with folinic acid (leucovorin) used to reduce side effects.
An outline written by upsc.help, not an official UPSC answer; every fact checked by a separate review. How we work
What the question asks
Three lists are wanted: indications, interactions with the mechanism of each, and adverse effects, each linked to the folate-blocking mechanism. Mention leucovorin and weekly dosing for safety.
Answer outline
Introduction
Methotrexate is an antifolate antimetabolite. In cancer it competitively inhibits dihydrofolate reductase, blocking thymidylate and purine synthesis and so DNA and RNA synthesis; in rheumatoid arthritis other immune-modulating mechanisms are thought to dominate.
Therapeutic indications
- Cancers: acute lymphoblastic leukaemia, choriocarcinoma and other trophoblastic neoplasms, solid tumours of breast, head and neck, lung and bladder, non-Hodgkin lymphoma, osteosarcoma.
- Autoimmune and inflammatory: rheumatoid arthritis (one of the first-line therapies), psoriasis and psoriatic arthritis, Crohn's disease, many forms of vasculitis; occasionally lupus, with tentative evidence.
- Obstetric: ectopic pregnancy when the tube has not ruptured; rarely medical abortion with misoprostol.
Drug interactions
- NSAIDs including aspirin: reduce renal clearance; fatal interactions reported, though low-dose use with monitoring is relatively safe.
- Penicillins may decrease methotrexate elimination; probenecid inhibits its excretion.
- Trimethoprim-sulfamethoxazole: organ toxicity when taken together.
- Proton pump inhibitors (omeprazole): raise plasma levels.
- Retinoids and trimethoprim: additive hepatotoxicity; cyclosporins and nitrous oxide potentiate haematological toxicity.
- Folic acid supplements can reduce effectiveness, though low-dose folic acid is commonly co-prescribed to cut adverse effects.
Side effects
- Blood abnormalities: leucopenia, anaemia, thrombocytopenia.
- Mucositis and stomatitis.
- Hepatotoxicity, among the most common adverse effects.
- Acute pneumonitis (rare but serious).
- Renal impairment.
- Teratogenic: stop at least four weeks before becoming pregnant; not safe during breastfeeding.
Safety measures
- Doses for autoimmune disease are usually taken weekly, not daily, to limit toxicity; folinic acid (leucovorin) is used to reduce side effects; folic acid is commonly co-prescribed to minimise adverse effects.
Conclusion
Methotrexate is effective across oncology and rheumatology, but its narrow margin demands attention to interactions, weekly dosing and monitoring.
Examples and data to cite
- Folinic acid (leucovorin) is used to reduce the side effects of methotrexate.
- Methotrexate treats ectopic pregnancy provided the fallopian tube has not ruptured.
Facts to remember
- Methotrexate competitively inhibits dihydrofolate reductase.
- Methotrexate is teratogenic and should be stopped at least four weeks before attempting pregnancy.
- Penicillins and probenecid reduce methotrexate elimination.
- Doses for autoimmune disease are usually weekly to limit toxicity.